@FierceMedDev: Neovasc reports higher 1Q revenues, lower expenses and losses. Story | Follow @FierceMedDev
@VarunSaxena2: St. Jude Medical sticking with renal denervation, releases EnligHTN study data at EuroPCR2014. Release | Follow @VarunSaxena2
@MichaelGFierce: Smallest, fastest nanomotor moves drugs and releases them on demand. Story from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Wound-care outfit Healogics is up for grabs with $1B pricetag. Article | Follow @EmilyWFierce
> Covidien ($COV) has released from a two-year study showing that its Stellarex drug-coated angioplasty balloon continues to be shown as safe and effective for treatment of peripheral arterial disease. Release
> The FDA has approved inx Medical's Nexus Hemorrhoid Ligator with EasyFire technology for the treatment of internal hemorrhoids. Release
Biotech News
@FierceBiotech: Editors @JohnCFierce, @DamianFierce and @EricPFierce will chat w/ experts and break down #ASCO2014. More to follow. Sponsored by @Covance. | Follow @FierceBiotech
@JohnCFierce: The R&D rankings: Big biotech once again makes Big Pharma look small. Report | Follow @JohnCFierce
@DamianFierce: So, who's going to run $CELG when Bob Hugin hangs it up? More | Follow @DamianFierce
@EmilyMFierce: ICYMI, this week's edition of FierceBiotech Research features lots of ASM2014 news. Report | Follow @EmilyMFierce
> Isis surges on promising head-to-head thrombosis drug study. Story
> Sarepta bets on DMD drug approval with a $25M plant buy. Article
> Third Rock builds a new West Coast biotech with an eye on cancer drugs. Story
Pharma News
@FiercePharma: Top story in FiercePharmaMarketing Weds: Who gets the likes when it comes to job hunting? Think J&J, Novartis and Biogen Idec. Article | Follow @FiercePharma
@TracyStaton: Here's an idea for AZ's full-of-promises execs: Tie pay to opportunity cost. More | Follow @TracyStaton
@EricPFierce: German Merck invests €50M in biologics capacity at Italy plant. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: CIA abandons use of vaccine programs for spying. Story from FierceVaccines | Follow @CarlyHFierce
> Delaware counts the cost of a Pfizer takeover of AstraZeneca. Item
> India commits to doubling its regulatory force. Story
> Roche becomes latest target of China corruption crackdown. Article
Pharma Manufacturing News
> Global sweep nabs 237 counterfeiting suspects. News
> Moderna names big names to manufacturing advisory board. Item
> Logistics company RXTPL rails at FDA for identifying it in drug seizure report. Article
> Teva recalls drugs made by India's Emcure over lab testing issues. Story
> India to double its drug inspection staff. Report
Vaccines News
> Pandemic flu vaccine research poses risk of unintended release. Story
> Glaxo announces 5-year price freeze for post-GAVI countries. Article
> CIA abandons use of vaccine programs for spying. More
> Sanofi C. diff vaccine shows immune response in PhII trial. Report
> Kymab, Gates Foundation to team up for malaria, HIV antigen discovery. Item